Cited by 49Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatmentsLysosomal Storage Disorders Research

Granulins rescue inflammation, lysosome dysfunction, lipofuscin, and neuropathology in a mouse model of progranulin deficiency

Open access
Root, Jessica, Mendsaikhan, Anarmaa, Taylor, Georgia, Merino, Paola, Nandy, Srijita, Wang, Minzheng, Araujo, Ludmilla Troiano, Ryu, Danny +5 more·2024·Cell Reports

Abstract

Progranulin (PGRN) deficiency is linked to neurodegenerative diseases, including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. Proper PGRN levels are critical for brain health; however, the function of PGRN is unclear. PGRN is composed of 7.5 repeat domains, called granulins, and processed into granulins inside the lysosome. PGRN is beneficial for neuronal health, but the role of individual granulins is controversial and unclear. We find that the expression of single granulins broadly rescues disease pathology in Grn −/− mice. Adeno-associated virus (AAV)-mediated expression of human granulin-2/F, granulin-4/A, or PGRN in Grn −/− mouse brain ameliorates dysregulated lysosomal proteins and lipids, microgliosis, and lipofuscinosis. Mechanistically, granulins localize to lysosomes in Grn −/− mouse brains or fibroblasts. These data support the hypothesis that PGRN is a precursor to granulins, which share a beneficial function inside the lysosome to maintain lipid and protein homeostasis to prevent neurodegeneration. Thus, granulins are potential therapeutics to treat FTD- GRN and related diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2024.114985

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BMP is an anionic, late-endosome/lysosome-specific glycerophospholipid that is reduced in several neurodegenerative disorders, including GRN-FTD.

    “BMP is an anionic, late-endosome/lysosome-specific glycerophospholipid that is reduced in several neurodegenerative disorders, including GRN-FTD. BMP stimulates lysosomal lipases and promotes cholesterol egress into the cytosol.137”

    From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [137]

    The Results section, “Lysosomal lipid dysregulation is rescued by a single GRN” (page unavailable), calls BMP an atypical endo-lysosomal lipid and reports reduced BMP in Grn−/− mouse brains. It does not establish that BMP is anionic or specific to late endosomes and lysosomes, or that BMP is reduced in several human neurodegenerative disorders, including FTD-GRN. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • BMP stimulates lysosomal lipases and promotes cholesterol egress into the cytosol.

    “BMP is an anionic, late-endosome/lysosome-specific glycerophospholipid that is reduced in several neurodegenerative disorders, including GRN-FTD. BMP stimulates lysosomal lipases and promotes cholesterol egress into the cytosol.137”

    From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [137]

    The Results section, “Lysosomal lipid dysregulation is rescued by a single GRN” (page unavailable), reports reduced BMP in Grn-deficient mouse brains and restoration after hGRN4 or hPGRN expression. It does not address whether BMP stimulates lysosomal lipases or promotes cholesterol egress into the cytosol; searches for those mechanisms found no supporting passage. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 97 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [72]Holler C, Taylor G, and Kukar T. (2016). Production, Detection, and Characterization of Proganulin (PGRN) and Granulins (GRNs) (held in Munich, Germany: Journal of Neurochemistry), p. 416. 138, 416.

Cited by

Sorted by citations

Authors
Root, J., Mendsaikhan, A., Taylor, G., Merino, P., Nandy, S., Wang, M., Araujo, L. T., Ryu, D., Holler, C., Thompson, B. M., Astarita, G., Blain, J.-F., & Kukar, T.
Affiliations
Emory University (US)
Corresponding author
Kukar, Thomas
Venue
Cell Reports
Publisher
Elsevier BV
Published
2024-12
Volume
43
Issue
12
Pages
114985
ISSN
2211-1247 (ISSN-L)
OpenAlex
W4404514683
Cited by
39
References
97
Citations by year
2026: 18 · 2025: 21
FWCI
10.43
Type
journal article
Language
en
Open access
Locations
  • Cell Reports (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Cancer Institute (P30CA138292)
  • National Institute on Aging (RF1AG079318)
  • School of Medicine, Emory University (F31NS117129)
  • BrightFocus Foundation
  • Alzheimer's Drug Discovery Foundation
  • Association for Frontotemporal Degeneration
  • National Institute of Neurological Disorders and Stroke (R01NS105971)
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
Keywords
progranulin, granulin, progranulin deficiency, frontotemporal dementia, lysosomal dysfunction, lipofuscin, microglial activation, neurodegeneration, lysosomes, AAV gene therapy, Parkinson's disease, Alzheimer's disease
MeSH terms
Progranulins, Granulins, Animals, Brain, Disease Models, Animal, Humans, Inflammation, Lipofuscin, Lysosomes, Mice, Inbred C57BL, Mice, Knockout, Mice, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review